Argentina delays commercial release of drought-tolerant GMO wheat, assessing trade disruptions

wheat field

Although the new drought-tolerant transgenic wheat developed by an Argentine company has the support of President Macri, the Minister of Production and the Secretary of Science for final approval, the Secretary of Agribusiness and the Owner of INTA oppose its commercial release.

The reason? The uncertainty of producers facing a wheat that does not yet have import approval in any other country in the world, and therefore, the possibility of losing strategic markets. In the recent meeting held at the Casa Rosada to discuss this problem, Macri finally gave officials 60 days to seek a consensus.

While no one disputes the advances in technology that allow increased production and competitiveness, some stakeholders worry about how importers of Argentine wheat will react to this drought-tolerant wheat.

The vice-president of the Rural Society (SRA) Carlos Vila Moret said that “we support technological advances, but we object from the commercial point of view.”

“Transgenic wheat is an important advance because it would increase production in marginal areas. But we must not lose sight of the reaction that markets can have….”added Vila Moret.

[Editor’s note: This article was originally published in Spanish. This summary was prepared with Google Translate.]

Read full, original article: Approval of transgenic wheat in Argentina delayed, despite support from the President

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-06-17-at-12.31.01-PM
Viewpoint: The dangerous influence of ‘woke’ post-modernism in science
Screenshot-2026-06-26-at-10.14.50-AM
Viewpoint: The facts behind the grifter-promoting wellness and anti-aging peptide craze: Don’t waste your money
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Jun-19-2026-04_11_20-PM
Daubert for Dummies—Scientific Reliability in U.S. Courts: Daubert, Rule 702, and Made-for-Litigation Evidence
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
ChatGPT-Image-Jun-26-2026-12_10_16-PM
Europe’s heat wave fueled recycled climate-denial narratives and harassment of climate scientists
ChatGPT-Image-Jun-26-2026-01_21_33-PM
How the dubious, Trump-backed, addictive drug kratom could enrich cabinet secretary Markwayne Mullin
Screenshot-2026-06-22-at-9.04.46-PM
Kennedy's nutrition prescription for medical schools: Real problem, bad cure
ChatGPT-Image-Jun-22-2026-01_30_11-PM
Facts & Fallacies podcast: Psychedelics for PTSD? Examining RFK, Jr's claims about ibogaine
Screenshot-2026-06-25-at-11.18.03-AM
Viewpoint: Appreciating a simpler past without swallowing the misleading ‘nature is healthier and safer’ myth
ChatGPT-Image-Jun-26-2026-11_34_33-AM
Viewpoint: RFK, Jr.’s vaccine subterfuge campaign now flies below the media radar
Screenshot-2026-06-15-at-1.55.27-PM
America's trust in Trump-Kennedy's CDC health recommendations is plunging
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.